HB 1527: Prohibitions Against Discriminatory Practices Relating to 340B Entities and 340B Drugs
GENERAL BILL by Franklin
Prohibitions Against Discriminatory Practices Relating to 340B Entities and 340B Drugs; Prohibits drug manufacturers from engaging in certain acts against acquisitions of 340B drugs by & delivery of such drugs to specified pharmacies; prohibits drug manufacturers from interfering with pharmacies’ rights to contract with 340B entities; prohibits certain acts by health insurers, HMOs, pharmacy benefit managers, or other third-party payors, or their agents, relating to reimbursement to 340B entity for 340B drugs; provides that each commission of certain acts constitutes violation of Florida Deceptive & Unfair Trade Practices Act & subjects violator to certain penalties.
Last Action: 6/16/2025 House - Died in Health Care Facilities & Systems Subcommittee
Bill Text: PDF
Bill History
| Date | Chamber | Action | 
|---|---|---|
| 2/28/2025 | House | • Filed | 
| 3/4/2025 | House | • 1st Reading (Original Filed Version) | 
| 3/5/2025 | House | • Referred to Health Care Facilities & Systems Subcommittee • Referred to Insurance & Banking Subcommittee • Referred to Health & Human Services Committee • Now in Health Care Facilities & Systems Subcommittee | 
| 5/3/2025 | House | • Indefinitely postponed and withdrawn from consideration | 
| 6/16/2025 | House | • Died in Health Care Facilities & Systems Subcommittee | 
